Rafferty Asset Management
ACOR

Rafferty Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Rafferty Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,759
Closed -$1.62M – 861
2019
Q2 		$1.62M Buy
1,759
+511
+41% +$628K 0.03% 468
2019
Q1 		$1.99M Buy
+1,248
New +$2.25M 0.03% 400

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rafferty Asset Management's ACOR Position: Q3 2019 in Review

Rafferty Asset Management sold out of Acorda Therapeutics (ACOR) in Q3 2019, closing a stake of 1,759 shares — an estimated $1.62M sold.

Rafferty Asset Management first reported a position in ACOR in Q1 2019 and held it in 2 quarters. The position peaked at $1.99M in Q1 2019. 151 funds tracked by Wall St. Rank hold ACOR as of Q3 2019.

  • Rafferty Asset Management reported no remaining Acorda Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 1,759 Acorda Therapeutics shares in Q3 2019, an estimated $1.62M.
  • Rafferty Asset Management first reported a position in Acorda Therapeutics in Q1 2019 and held it in 2 quarters.
  • Rafferty Asset Management's Acorda Therapeutics position peaked at $1.99M in Q1 2019.
  • 151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2019.

Based on Rafferty Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.